We have cloned, determined the primary structure of, and overexpressed in Escherichia coli the gene mvaA, which is the 1,287-base structural gene for the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase [EC 1.1.1.88] of Pseudomonas mevalonii. The amino acid composition of HMG-CoA reductase agreed with that predicted from the nucleotide sequence of mvaA, and DNA-derived sequences were identical to all experimentally determined peptide sequences. Overexpression of mvaA in E. coli yielded quantities of HMG-CoA reductase over 1,500-fold higher than those present in control cultures. Comparison of the primary structure of the P. mevalonii enzyme with the DNA-derived primary structure for a mammalian HMG-CoA reductase revealed two regions of similarity suggestive of functional relatedness. An open reading frame, ORF1, lies on the 3' side of mvaA, and a potential ribosome-binding site for ORF1 overlaps the termination codon of mvaA.Several microorganisms can utilize the isoprenoid precursor mevalonate as a sole carbon source (4,13,16,49, 50,52
MATERIALS AND METHODSBacterial strains, plasmids, bacteriophage, and culture conditions. Plasmid cloning and M13 propagation were conducted in E. coli JM103 (36), using M9 medium, L broth (34), B broth, or 2x YT medium (36). Phage lambda was propagated in E. coli Q359 (25) on NZYM medium (34). Plasmids pUC18 and pUC19, phage derivatives M13mpl8 and M13mpl9, and lambda EMBL4 have been previously described (14, 54). Plasmid pKK177-3, a shortened version of pKK223-3 (9) in which the remainder of the tet gene between the BamHI and PvuII sites has been deleted (J. Brosius, personal communication), was obtained from Scott Buckel, Carnegie-Mellon University, Pittsburgh, Pa.Purification and assay of P. mevalonii HMG-CoA reductase. HMG-CoA reductase activity was assayed and the enzyme was purified to homogeneity as described by Gill et al. (17).Reduction, alkylation, and cleavage of protein with cyanogen bromide. Purified HMG-CoA reductase (450 nmol) was dialyzed against 9% (vol/vol) formic acid, lyophilized, and suspended in reduction-alkylation buffer (130 mM Tris [pH 8.0], 6 M guanidine hydrochloride, 1 mg of EDTA per ml) that contained dithioerythritol in a fourfold molar excess over the predicted sulfhydryl content. The solution was incubated at room temperature for 4 h and then dialyzed against reduction-alkylation buffer. Cysteine residues were alkylated by treatment first with 2 pCi of [1-14C]iodoacetamide (specific activity, 53 Ci/mol) and then with nonradioactive iodoacetamide. (Use of [14C]iodoacetamide was intended to facilitate identification of cysteine-containing peptides. However, no peptide yielded enough sequence to ascertain the positions of the two cysteine residues.) After 30 min, excess dithioerythritol was added to neutralize unreacted iodoacetamide. The reduced, alkylated protein was then dialyzed three times against 9% (vol/vol) formic acid, lyophilized, and suspended in 70% (vol/vol) formic acid. A crystal of cyanogen bromide was added, and cleavage was...